Risperidone Treatment of Children and Adolescents With Pervasive Developmental Disorders: A Prospective, Open-Label Study
Open Access
- 1 May 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 36 (5) , 685-693
- https://doi.org/10.1097/00004583-199705000-00020
Abstract
No abstract availableKeywords
Funding Information
- US Public Health Service (HD-03008 and MH-30929)
- General Clinical Research Centers Program, National Center for Research Resources, NIH (MO1-RR06022)
This publication has 27 references indexed in Scilit:
- Risperidone in Young Children with Pervasive Developmental Disorders and Other Developmental DisabilitiesJournal of Child and Adolescent Psychopharmacology, 1996
- Risperidone Treatment of Children and Adolescents: Increased Risk of Extrapyramidal Side Effects?Journal of Child and Adolescent Psychopharmacology, 1995
- Risperidone in Adults with Autism or Pervasive Developmental DisorderJournal of Child and Adolescent Psychopharmacology, 1995
- Risperidone Effects in Treatment-Resistant Adolescents: Preliminary Case ReportsJournal of Child and Adolescent Psychopharmacology, 1995
- Pharmacokinetics and safety of risperidone in autistic childrenPediatric Neurology, 1994
- Effects of atypical antipsychotic agents on social behavior in rodentsPharmacology Biochemistry and Behavior, 1993
- Acute tryptophan depletion in autistic disorder: A controlled case studyBiological Psychiatry, 1993
- Risperidone as add‐on therapy in behavioural disturbances in mental retardation: a double‐blind placebo‐controlled cross‐over studyActa Psychiatrica Scandinavica, 1993
- Efficacy and Tolerability of a New Antipsychotic Compound (Risperidone): Results of a Pilot StudyPharmacopsychiatry, 1991
- A Scale for Rating Symptoms of Patients with the Syndrome of Autism in Real Life SettingsJournal of the American Academy of Child Psychiatry, 1986